OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

BACKGROUND: There is uncertainty about the chemotherapy sensitivity of some oestrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancers. Multiparameter assays that measure the expression of several tumour genes simultaneously have been developed to guide...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Health Technol Assess
Κύριοι συγγραφείς: Stein, Robert C, Dunn, Janet A, Bartlett, John Ms, Campbell, Amy F, Marshall, Andrea, Hall, Peter, Rooshenas, Leila, Morgan, Adrienne, Poole, Christopher, Pinder, Sarah E, Cameron, David A, Stallard, Nigel, Donovan, Jenny L, McCabe, Christopher, Hughes-Davies, Luke, Makris, Andreas
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: NIHR Journals Library 2016
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781175/
https://ncbi.nlm.nih.gov/pubmed/26867046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta20100
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια